News

United States Antimony's Upcoming Earnings: What to Expect

United States Antimony's Upcoming Earnings: What to Expect

United States Antimony's Earnings Forecast Overview

United States Antimony (AMEX: UAMY) is set to release its quarterly earnings report soon, sparking interest among investors. This announcement is pivotal as it provides insights into the company's financial trajectory. As anticipation builds, let's delve into what to expect from this earnings release.

Analyst Predictions for Earnings Per Share

Experts forecast that United States Antimony will report an earnings per share (EPS) of $0.01. This projection indicates cautious optimism about the company’s profitability and its ability to meet shareholder expectations.

Importance of Upcoming Earnings Announcement

The upcoming earnings announcement is critical for shareholders and potential investors. News of surpassing earnings estimates would likely boost market confidence, while any disappointing results may lead to volatility in share prices.

Past Earnings Performance

Looking back, the company's last quarter saw an EPS that missed predictions by $0.03. Despite this setback, the share price increased by 4.97% following the announcement, indicating resilience and possible investor confidence.

Overview of Recent Stock Performance

As of the latest trading session, shares of United States Antimony were priced at $7.67. Over the past year, stock performance has surged significantly, reflecting an impressive gain of 1176.23%. This upward trend could suggest a positive outlook from long-term investors.

Market Sentiments on United States Antimony

Investor sentiment plays a vital role in stock performance. The consensus among analysts gives United States Antimony a "Buy" rating based on three reviews. With a one-year price target set at $6.0, analysts note a potential downside of 21.77%—a point of concern.

Comparing Analyst Ratings with Industry Peers

When evaluating United States Antimony's standing within the industry, it’s essential to compare with similar companies:

  • Lithium Americas shows a neutral outlook, with a one-year price target of $5.71, indicating a possible 25.55% decline.
  • Nexa Res also holds a neutral stance, with a target of $6.2, suggesting a downside of 19.17%.
  • Conversely, Compass Minerals International is rated as underperforming, with a target of $18.0, reflecting a substantial potential upside of 134.68%.

Comprehensive Peer Analysis

Analyzing key financial metrics, United States Antimony has its strengths and weaknesses:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
United States AntimonyBuy187.34%$2.84M0.51%
Lithium AmericasNeutral0.00%$-10K-2.00%
Nexa ResNeutral7.62%$153.96M7.43%
Compass Minerals InternationalUnderperform5.77%$41.20M-6.99%

Conclusions from Peer Comparisons

United States Antimony's ranking in terms of revenue growth and gross profit falls below that of competitors, though it maintains a middle-tier position for return on equity. This presents an opportunity to evaluate its operational effectiveness.

Diving Deeper into United States Antimony

United States Antimony Corp is an integrated mining company engaged in the mining, transportation, milling, smelting, and selling of minerals. Their operations span two main segments: antimony and zeolite products. Notably, the bulk of their revenue is derived from operations in the United States.

Financial Performance at a Glance

Market Capitalization: Currently, the company's market capitalization lags behind industry norms, which could signal growth opportunities or operational hurdles.

Remarkable Revenue Increase: A significant highlight is that as of the mid-year, the company achieved a remarkable 187.34% revenue growth rate. This upswing demonstrates an impressive ability to enhance top-line earnings relative to industry averages.

Profitability Metrics: The net margin is commendable, showcasing strong control over operational costs with a 1.71% net margin. However, the 0.51% return on equity indicates ongoing challenges in maximizing capital returns.

Managing Debt Effectively: The company also benefits from a favorable debt-to-equity ratio of 0.03, suggesting a lower dependence on debt to finance its operations, which instills confidence among investors.

Frequently Asked Questions

What is the expected EPS for United States Antimony?

The expected EPS for United States Antimony is forecasted to be $0.01.

How did the last earnings report impact share prices?

Last quarter's EPS missed expectations, yet shares saw a 4.97% increase following the results, indicating market resilience.

What is the current stock price of United States Antimony?

The current trading price for United States Antimony is $7.67.

How do analyst ratings compare among peers?

United States Antimony has a "Buy" rating, while several peers have either neutral or underperforming ratings.

What is the company's main product focus?

United States Antimony primarily focuses on mining, transportation, milling, and smelting of antimony and zeolite products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LV Petroleum Expands Footprint with Key Acquisitions

Updated Category News Views 0

LV Petroleum's Bold Moves in July Ever seen a company expand across four states in a blink? LV Petroleum's been hustling like a player with a fresh hand of aces. They shut July down with restaurant openings and a fancy new travel center under their belt in states as spread out as Arizona, Texas, Nevada, and Ohio. Now that's a wide net they're casting, all in the name of...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading
PGI's Award-Winning Febreze Cabin Air Filters Shines Again

Updated Category News Views 9

A Breath of Fresh Air for the Auto Aftermarket How often do you even think about the quality of air inside your vehicle? If you're like most folks, it's not often. But Premium Guard Inc. (PGI) has been busy changing that narrative. Their Febreze Cabin Air Filters just snagged the 2026 MOTOR Top 20 Awards, proving that they're not just a pretty face in the automotive...

Continue Reading
Taiwan's Machine Emerges as Heavy-Tonnage Game Changer

Updated Category News Views 2

Every once in a while, the machinery scene gets rocked by something that genuinely raises eyebrows, and it seems Chuan Lih Fa Machinery Works Co., Ltd. (CLF) has just delivered one of those moments. This isn't just any old injection molding machine—it's Taiwan's very first 5000-ton giant, crafted with robust precision and dispatched straight to a major U.S. logistics...

Continue Reading
Courtesy Auto Group Expands with Tucson Dealerships Buy

Updated Category News Views 4

Moving Pieces in the Automotive Puzzle Here's one for the books, folks. Automotive dealership chessboard gets another shuffle. Scott Gruwell, the big wheel behind Courtesy Automotive Group, has snatched up Watson Chevrolet and Infiniti of Tucson. Just one more notch in someone's power belt—operations now rolling under new banners as Courtesy Chevrolet and Courtesy...

Continue Reading
Ribbonwire Ranch Hits Sheetz Milestone with Campaign

Updated Category News Views 3

Where Beef Snacks Meet Road Tales Just a year ago, Ribbonwire Ranch, a small Texas-based beef snack producer, made its debut at Sheetz stores. Now, they're not just another brand on the shelf; they're weaving tales from the road with their latest venture, the "Dashboard Diaries" campaign. If you're wondering how a beef snack producer finds itself in an eight-week...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 0

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 0

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
Max Stock Expands with Strategic Logistics Center

Updated Category News Views 1

Expansion in Full Swing In a move that might get tongues wagging in the boardrooms across Israel, Max Stock Limited (TASE: MAXO) just signed a hefty lease for a logistics center in Ofakim. This isn't just a modest expansion—it's a jaw-dropper at about 45,000 square meters. We're talking about a major upgrade that'll beef up their logistical backbone as they continue...

Continue Reading
Beyoncé Drops Remastered 'B'DAY'; Celebrates Legacy

Updated Category News Views 0

Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Options Market Trends for Nano Nuclear Energy

Updated Category News Views 109

Exploring Current Trends in the Options Market for Nano Nuclear Energy Recent movements among financial giants suggest a notable bearish sentiment surrounding Nano Nuclear Energy. Analyzing the options history for Nano Nuclear Energy (NNE), we have identified 12 unusual trades that indicate evolving market perspectives. In our detailed assessment, we discovered that...

Continue Reading
NeoImmuneTech Unveils Breakthrough Results for CAR-T Therapy

Updated Category News Views 186

Promising Developments in CAR-T Therapy with NT-I7 NeoImmuneTech, Inc. has achieved significant advancements in enhancing CAR-T cell therapies, which are innovative treatments designed to combat cancer. Recent interim results from the Phase 1b clinical trial demonstrate the potential benefits of combining NT-I7 (efineptakin alfa) with CAR-T therapy, highlighting its...

Continue Reading
Owkin Teams Up with AstraZeneca to Transform Breast Cancer Testing

Updated Category News Views 156

Owkin made headlines back in 2024 when it teamed up with AstraZeneca, looking to revolutionize breast cancer diagnostics by developing an advanced tool for pre-screening gBRCA mutations. Traders were quick to pick up on this collaboration, given the critical nature of BRCA testing and its potential market impact. But let’s peel back the layers on this deal. Partnership...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 342

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading
Discover the 2026 Best Wellness Employer Survey Insights

Updated Category News Views 117

Wellness Workdays Unveils the 2026 Best Wellness Employer Survey In a significant move towards enhancing employee health and wellness, Wellness Workdays has launched the 2026 Best Wellness Employer survey. This initiative invites organizations to showcase their dedication to improving workplace well-being through sustainable practices and measurable results. Collaboration...

Continue Reading